These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials. Romanelli RJ; Wu FM; Gamba R; Mojtabai R; Segal JB Depress Anxiety; 2014 Aug; 31(8):641-52. PubMed ID: 24390912 [TBL] [Abstract][Full Text] [Related]
9. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD). Del Casale A; Sorice S; Padovano A; Simmaco M; Ferracuti S; Lamis DA; Rapinesi C; Sani G; Girardi P; Kotzalidis GD; Pompili M Curr Neuropharmacol; 2019; 17(8):710-736. PubMed ID: 30101713 [TBL] [Abstract][Full Text] [Related]
10. Obsessive-compulsive spectrum disorders: a review of the evidence-based treatments. Ravindran AV; da Silva TL; Ravindran LN; Richter MA; Rector NA Can J Psychiatry; 2009 May; 54(5):331-43. PubMed ID: 19497165 [TBL] [Abstract][Full Text] [Related]
11. Assessment and management of treatment-refractory obsessive-compulsive disorder in children. Bloch MH; Storch EA J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):251-62. PubMed ID: 25791142 [TBL] [Abstract][Full Text] [Related]
12. A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder. Matsunaga H; Nagata T; Hayashida K; Ohya K; Kiriike N; Stein DJ J Clin Psychiatry; 2009 Jun; 70(6):863-8. PubMed ID: 19422759 [TBL] [Abstract][Full Text] [Related]
13. Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials. Dold M; Aigner M; Lanzenberger R; Kasper S Int J Neuropsychopharmacol; 2013 Apr; 16(3):557-74. PubMed ID: 22932229 [TBL] [Abstract][Full Text] [Related]
14. [Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art]. Kordon A; Zurowski B; Wahl K; Hohagen F Nervenarzt; 2011 Mar; 82(3):319-20, 322-4. PubMed ID: 21340636 [TBL] [Abstract][Full Text] [Related]
15. [Effectiveness and tolerability of addition of risperidone in obsessive-compulsive disorder with poor response to serotonin reuptake inhibitors]. Arias Horcajadas F; Soto JA; García-Cantalapiedra MJ; Rodríguez Calvin JL; Morales J; Salgado M Actas Esp Psiquiatr; 2006; 34(3):147-52. PubMed ID: 16736387 [TBL] [Abstract][Full Text] [Related]
16. Issues in the pharmacological treatment of obsessive-compulsive disorder. Math SB; Janardhan Reddy YC Int J Clin Pract; 2007 Jul; 61(7):1188-97. PubMed ID: 17511795 [TBL] [Abstract][Full Text] [Related]
18. Combining Drug and Psychological Treatments for Obsessive- Compulsive Disorder: What is the Evidence, When and for Whom. Albert U; Di Salvo G; Solia F; Rosso G; Maina G Curr Med Chem; 2018; 25(41):5632-5646. PubMed ID: 28707590 [TBL] [Abstract][Full Text] [Related]
19. [Efficacy of antipsychotic augmentation therapy in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomised, placebo-controlled trials]. Dold M; Aigner M; Lanzenberger R; Kasper S Fortschr Neurol Psychiatr; 2011 Aug; 79(8):453-66. PubMed ID: 21809258 [TBL] [Abstract][Full Text] [Related]